🔗 Share this article

Given that the US continues making unprecedented adjustments to its immunization guidelines, one figure has emerged somewhat surprisingly: Høeg, an American of Danish descent sports medicine doctor and epidemiologist who first made her name by casting doubt on coronavirus shots throughout the pandemic and has focused upon potential deaths following Covid vaccination in her brief time at the US Food and Drug Administration (FDA).

Planned Overhauls to Pediatric Vaccine Program

Health officials planned to unveil major revisions to the pediatric immunization program in December, aligning the US with the Danish vaccine program, according to reports – a major change that would place the US at odds with many the world with little proof for benefit. This reveal has been postponed until the new year.

Rather than Vinay Prasad, Dr. Høeg is scheduled to present at the meeting. She was recently named interim head of the FDA’s CDER, the fifth individual to lead the division this calendar year.

Consolidating Power at the Regulatory Body

This interim role may indicate a tighter collaboration between the drug and biologics branches as Dr. Høeg and Prasad strengthen their influence at the FDA – and it points to a increased emphasis upon reevaluating long-standing vaccines at the FDA.

Dr. Høeg has frequently advocated for halting certain childhood immunization guidelines in the US in order to be more similar to the Danish model, a society with universal health coverage and a number of inhabitants approximately the size of Wisconsin’s.

In her initial statements, she has kept her attention on vaccines – typically the responsibility of Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to pharmaceutical oversight.

Doubts Over Qualifications

Dr. Høeg has little discernible track record in drug development, oversight or administrative roles, which has been customary for former directors of the biologics center. She has been employed at the FDA as a key advisor to the commissioner and the vaccine center since March.

“It seems she lacks to have the necessary background” for leading the drug-regulation department, remarked a neurologist and psychiatrist. “She has not conducted a randomized controlled trial. She lacks experience in leading a major agency. She has no expertise in pharmaceutical oversight.”

Previous heads of CBER would “be deeply familiar with legal statutes and the research of drug development”, noted Dr. Janet Woodcock. “Clearly, she lacks the kind of background that previous people who led the center have had.”

CDER has an vast range of responsibilities at the FDA, Woodcock pointed out.

“Everybody just focuses on the innovative therapies, but the off-patent medication office approves a multitude of generic medications. There’s a biologic copycat branch, OTC medication office and more, and every single one must be supervised,” Woodcock explained. “The area you overlook, that is precisely what that I always told people is going to come back to haunt you.”

Furthermore, a significant administrative aspect to the job, which oversees more than 5,000 employees. “It’s a massive management job, if you execute it properly,” Woodcock said.

Response and Controversial Policies

In response to concerns about Dr. Høeg's credentials and whether this selection represents greater collaboration among agency officials on immunizations, a spokesperson stated that the “inquiries stem from flawed premises”.

“Her resume is consistent with the duties of her job,” the spokesperson stated, pointing to the months Dr. Høeg spent counseling the agency head on “medication safety and oversight research, including computational safety modeling and shot safety tracking”.

As acting director, Dr. Høeg inherits the commissioner’s new expedited review system, a contentious expedited medication authorization process that apparently troubled her former heads. “How are these medications being selected for this expedited pathway? Who is making the decisions?” Dr. Howard asked. “There is a lot of confidentiality occurring at the regulatory body right now.”

In general, he said, “the FDA appears to be shifting towards less stringent oversight of most medications, except for vaccines.”

Documented Past Work on Vaccines

Concerning immunizations, Høeg has a clearer, if problematic, history, critics have noted. She released a research paper using unconfirmed crowd-sourced reports to assess the rate of heart inflammation after Covid vaccination. She consulted for the Florida chief medical officer Dr. Joseph Ladapo, who was said to have changed statistics to imply COVID-19 vaccinations are more dangerous than they are.

Part of her “desired changes” for the incoming government included altering rules for novel immunizations and discontinuing “optional” vaccines, she stated following the vote on a online show. At the agency, Høeg has reportedly proposed excluding teenage boys from getting COVID-19 vaccinations.

“She is an all-around dogmatist who commences with her beliefs and works backwards to retrofit the science in a very disingenuous, dishonest fashion,” Dr. Howard argued.

Taking Control and a “Revenge Tour”

Dr. Høeg joined fellow dissenters, {like|